| Application no. and date | 16880113.2 (espacenet) (Federated) (European Patent Register), 20161222 | | Patent/reg. no. and date | DK/EP 3393468, 20220914 | | Publication date | 20181031 | | Priority no. and date | US 201562271087 P, 20151222, US 201662428964 P, 20161201 | | EP pub. no. and date |
EP 3393468 20181031 | | Effective date | | | Applicant/owner | X4 Pharmaceuticals, Inc., 61 North Beacon Street, 4th Floor
Boston MA 02134, US | | Applicant ref. no. | 167617/BT/SD | | Inventor | RAGAN, Paula Marie, 281 School Street
Belmont
Massachusetts 02478, US,
ARBEIT, Robert D, 24 Oldham Road
West Newton
Massachusetts 02465, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K, DK | | Opponent | | | IPC Class | A61K 31/4709 (2006.01) , A61K 9/00 (2006.01) , A61K 9/14 (2006.01) , A61K 9/48 (2006.01) , A61P 17/12 (2006.01) , A61P 35/00 (2006.01) , A61P 37/04 (2006.01) | | Title | Fremgangsmåder til behandling af en immundefektsygdom | | Int. application no. | US2016068394 | | Int. publication no. | WO2017112894 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
